Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Antineoplastic Agents (6)
- Chemotherapy, Adjuvant (4)
- Surgical Procedures, Operative (4)
- Antibodies, Monoclonal (3)
- Clinical Trials as Topic (3)
-
- Drug-Related Side Effects and Adverse Reactions (3)
- Radiotherapy (3)
- Survival Rate (3)
- Bevacizumab (2)
- Breast Neoplasms (2)
- Cancer Vaccines (2)
- Colorectal Neoplasms (2)
- Dasatinib (2)
- Epinephrine (2)
- Fatigue (2)
- Hodgkin Disease (2)
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2)
- Leukemia, Myeloid, Acute (2)
- Magnetic Resonance Imaging (2)
- Neoadjuvant Therapy (2)
- Neoplasm Staging (2)
- Neoplasms -- therapy (2)
- Norepinephrine (2)
- Philadelphia Chromosome (2)
- Pyrimidines (2)
- Radiotherapy, Intensity-Modulated (2)
- Stem Cell Transplantation (2)
- Tomography, X-Ray Computed (2)
- Younes, Anas (2)
- AZD 6244 (1)
Articles 1 - 10 of 10
Full-Text Articles in Medicine and Health Sciences
Oncology, Volume 56, Number 11-12, November - December 2011, Sarah Bronson, Zach-Bryan Bogannan-Tutt
Oncology, Volume 56, Number 11-12, November - December 2011, Sarah Bronson, Zach-Bryan Bogannan-Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Transoral Laser Microsurgery for Laryngeal and Oropharyngeal Tumors: A minimally invasive surgery for treating cancers of the larynx and oropharynx has cute rates similar to those of open surgery and radiation therapy in selected patients.
- Exploring Causes of and Treatments for Neuropathy in Cancer Patients: Among the most troubling side effects of cancer treatment in some patient is chronic chemotherapy neuropathy syndrome, in which tingling, numbness, and pain in the hands and feet persist long after the completion of treatment
- Prostate Cancer Screening: Patient should understand the purpose and limitations of the prostate-specific antigen test
- HOUSE CALL: Smoking Cessation: Medications …
Oncology, Volume 56, Number 10, October 2011, Bryan Tutt, Sunni Hosemann
Oncology, Volume 56, Number 10, October 2011, Bryan Tutt, Sunni Hosemann
OncoLog MD Anderson's Report to Physicians (All issues)
- Treating Cancer in Pregnant Patients: Pregnancy is usually a joyous, hopeful time; a cancer diagnosis can be devastating. When pregnancy and cancer occur together, they present special challenges for patients and physicians. Fortunately, these challenges often can be overcome by a multidisciplinary approach to treatment
- Compass: Non-Small Cell Lung Cancer: Stage IIIA-Many factors affect treatment sequences
- HOUSE CALL: Understanding Cancer Risk and Risk Factors: Your risk factors might affect your need for cancer screening
Oncology, Volume 56, Number 09, September 2011, Joe Munch, Bryan Tutt
Oncology, Volume 56, Number 09, September 2011, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Novel Agents for Castrate-Resistant Prostate Cancer Include Potent Androgen Blockers and Immunotherapies: Despite progress in screening and therapy, prostate cancer continues to be a leading cause of cancer death among men worldwide
- New Targeted Therapy Offers Hope in Relapsed Hodgkin and Anaplastic large-Cell Lymphoma: The U.S. Food and Drug Administration (FDA) has approved the first new drug for Hodgkin Lymphoma since 1977
- HOUSE CALL: Colorectal Cancer Screening: Risk factors determine who should be screened and how often
- IN BRIEF: Everolimus may Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer Patients
Oncology, Volume 56, Number 08, August 2011, Stephanie Deming, Sunni Hosemann
Oncology, Volume 56, Number 08, August 2011, Stephanie Deming, Sunni Hosemann
OncoLog MD Anderson's Report to Physicians (All issues)
- Addressing the Cardiac Complications of Cancer Treatment: Patients with cancer surviving longer than ever after treatment, and new targeted therapy agents are being introduced into the clinic with increasing frequency. These advances are cause for optimism, but they have also led to an increased incidence of cardiac complications of cancer therapy
- Compass: Early- and Intermediate-Stage Gastric Cancer: Neoadjuvant of adjuvant treatments offer higher cure rates than surgery alone
- HOUSE CALL: Managing Disease-Related Fatigue- Patients and doctors offer can make fatigue less severe
Oncolog, Volume 56, Number 07, July 2011, Kate Newberry, Joe Munch
Oncolog, Volume 56, Number 07, July 2011, Kate Newberry, Joe Munch
OncoLog MD Anderson's Report to Physicians (All issues)
- A New Era in Treating Patients Who Have Multiple Myeloma: During the past decade, several novel treatments have extended the median survival time for patients with multiple myeloma from less than 3 years to more than 7 years, and researchers are working to further improve treatment
- Landmark Trial Shows Potential of Low-Dose Computed Tomography for Lung Cancer Screening
- HOUSE CALL: Eating Healthier May Reduce Cancer Risk: Healthy eating habits may also increase energy and heart health
- IN BRIEF: Inotuzumab Ozogamicin Shows Promise for Acute Lymphoblastic Leukemia Treatment
Oncolog, Volume 56, Number 06, June 2011, John H. Mccool, Sunni Hoseman
Oncolog, Volume 56, Number 06, June 2011, John H. Mccool, Sunni Hoseman
OncoLog MD Anderson's Report to Physicians (All issues)
- MD Anderson Celebrates 70th Anniversary: Its first clinical facility was a converted Army barracks, its first headquarters was renovated residential estate near downtown Houston, and its first cancer research was conducted by four scientists in a former horse stable
- Compass: Stage II or III Soft Tissue Sarcoma-Chemotherapy and radiation therapy before or after surgery benefit patients
Oncolog, Volume 56, Number 04-05, April-May 2011, Zach Bohannan, Bryan Tutt
Oncolog, Volume 56, Number 04-05, April-May 2011, Zach Bohannan, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Understanding and Managing Multiple Endocrine Neoplasia Syndromes: Endocrine tumors caused by multiple endocrine neoplasia syndromes (MEN) pose a dual threat-both from the tumors' potential for growth or metastasis and from their hormonal secretions
- Two-Stage Resection and Improved Chemotherapy Regimens Lengthen Survival for Patients with Lever Metastasis from Colorectal Cancer
- HOUSE CALL: Saving a Life by Donating Stem Cells: Fact about stem cell transplants
- IN BRIEF: Study Reveals How EZH2 Protein Promotes Breast Tumor-Initiating Cell Growth
Oncolog, Volume 56, Number 03, March 2011, Bryan Tutt, Joe Munch
Oncolog, Volume 56, Number 03, March 2011, Bryan Tutt, Joe Munch
OncoLog MD Anderson's Report to Physicians (All issues)
- Glioblastoma Cure Remains Elusive Despite Treatment Advances: Aggressive surgery followed by radiation therapy and chemo-therapy offers hope of long-term survival for some patients with glioblastoma, but for most glioblastoma patients, the prognosis is poor
- Assessing and Addressing the Biological Effects of Stress in Cancer Patients: Stress has long been linked to cancer progression. But the precise mechanisms by which stress exacts its pro-tumor effects are not fully understood
- MD Anderson One of Four Centers to Test Cancer Cell Detection Chip: A new test that could monitor the effectiveness of cancer treatment
- HOUSE CALL: Yoga and Tai Chi: Two distinct disciplines …
Oncolog, Volume 56, Number 02, February 2011, Joe Munch, John Lebas
Oncolog, Volume 56, Number 02, February 2011, Joe Munch, John Lebas
OncoLog MD Anderson's Report to Physicians (All issues)
- Risk-Based Cancer Screening: M.D. Anderson's revised guidelines offer more precise individualized recommendations on screening for common cancers.
- Screen Guidelines in Brief
- Electronic Navigation Biopsy for Peripheral Lung Lesion Diagnosis
- House Call: Couples and Cancer: Cancer-Related Issues Can Disrupt Relationships
- in Brief: Researchers Find Glioblastoma's Resistance to Treatment Rooted in Immunosuppression
Oncolog, Volume 56, Number 01, January 2011, Bryan Tutt, Sunni Hosemann
Oncolog, Volume 56, Number 01, January 2011, Bryan Tutt, Sunni Hosemann
OncoLog MD Anderson's Report to Physicians (All issues)
- New Drug Control Symptoms of Myeloproliferative Disorders and Improve Quality of Life for Patients: Recent clinical trials have demonstrated that a new class of drugs can effectively treat myeloproliferative disorders
- Compass: Metastatic Melanoma: Experimental treatments could be preferable to standard therapies for metastatic melanoma
- HOUS CALL: Breast Awareness: Guidelines recommend breast awareness rather than formal self-exams